ライフサイエンスコーパス: neuroprotective drug

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 rotection warranting its clinical trial as a neuroprotective drug.

2 ially enhance the future assessment of novel neuroprotective drugs.

3 made between the effectiveness of potential neuroprotective drugs.

4 nt with antibiotics, anti-edema measures and neuroprotective drugs.

5 cascade has helped stimulate development of neuroprotective drugs aimed at limiting brain injury in

6 performed an initial screening for potential neuroprotective drugs among a group of flavonoids by usi

7 proach to identify ethoxyquin as a potential neuroprotective drug and carried out additional biochemi

8 cline is an established antiinflammatory and neuroprotective drug and may provide a novel approach to

9 ted imaging evaluation) and therapeutic (eg, neuroprotective drugs and treatments for haemorrhagic st

10 ms and for identifying potential targets for neuroprotective drugs at pre-clinical stages.

11 Thus, AUTEN-99 serves as a potent neuroprotective drug candidate for preventing and treati

12 might offer a new approach in the design of neuroprotective drug candidates.

13 The use of more refined outcomes and truly neuroprotective drugs, coupled with more efficient trial

14 Here we show that ATP and the neuroprotective drug dexpramipexole (DEX) inhibited an i

15 (Li) has garnered considerable interest as a neuroprotective drug for a broad range of nervous system

16 cal trials encourage exploration of NBP as a neuroprotective drug for the treatment of ischemic strok

17 rimental and clinical research to identify a neuroprotective drug for the treatment of traumatic brai

18 tetrahydropyridine (MPTP) models to identify neuroprotective drugs for Parkinson's disease (PD).

19 Our aim was to assess TCH346 as a neuroprotective drug in patients with Parkinson's diseas

20 The failure of most neuroprotective drugs in clinical trials has been due to

21 ns and may represent an important target for neuroprotective drugs in degenerative diseases involving

22 on the potential targets for development of neuroprotective drugs in Parkinson's disease and suggest

23 ess of several antiepileptic, analgesic, and neuroprotective drugs is attributable to state-dependent

24 ology and the development of new multitarget neuroprotective drugs is promising and attractive.

25 the future, combinations of thrombolytic and neuroprotective drugs may be used to attempt maximum rat

26 Neuroprotective drugs may be useful as an adjunct approa

27 hods for assessing the potential benefits of neuroprotective drugs on RGCs which have been injured by

28 We show that the neuroprotective drug riluzole increased the amount of HS

29 alcium increases and can be activated by the neuroprotective drug riluzole.

30 Third, neuroprotective drugs should be tested in combination wi

31 state affinity or use-dependent block by the neuroprotective drug sipatrigine (compound 619C89).

32 PD has permitted the development of putative neuroprotective drugs that might slow or stop disease pr

33 ulating agent alone or in combination with a neuroprotective drug to symptomatic SOD1G93A mice reduce

34 tion in AD increases, it is anticipated that neuroprotective drugs to slow or prevent neuronal dysfun

35 and identify targets for the development of neuroprotective drugs, we developed a high-throughput RN

36 tion of Neotrofin, a cognitive-enhancing and neuroprotective drug, with the heme oxygenase system.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。